Israel - Hebrew - Ministry of Health

bayer israel ltd - regorafenib - טבליות מצופות פילם - regorafenib 40 mg - regorafenib - regorafenib - stivarga is indicated for the treatment of patients with metastatic colorectal cancer (crc) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf therapy, and if kras wild-type, an anti-egfr therapy.for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumors (gist) who have been previously treated with imatinib mesylate and sunitinib malate

Israel - Hebrew - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 100 mg - palbociclib

Israel - Hebrew - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 125 mg - palbociclib

Israel - Hebrew - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 75 mg - palbociclib

Israel - Hebrew - Ministry of Health

incyte biosciences israel ltd, israel - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 15 mg - ponatinib

Israel - Hebrew - Ministry of Health

incyte biosciences israel ltd, israel - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 15 mg - ponatinib

Israel - Hebrew - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 15 mg - ponatinib

Israel - Hebrew - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 15 mg - ponatinib

Israel - Hebrew - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 15 mg - ponatinib

Israel - Hebrew - Ministry of Health

medison pharma ltd - ponatinib as hydrochloride - טבליות מצופות - ponatinib as hydrochloride 30 mg - ponatinib